The effects of gender-affirming hormone therapy on myocardial, hepatic, pancreatic lipid content, body fat distribution and other cardiometabolic risk factors: A magnetic resonance-based study in transgender individuals

The effects of gender-affirming hormone therapy on myocardial, hepatic, pancreatic lipid content, body fat distribution and other cardiometabolic risk factors: A magnetic resonance-based study in transgender individuals

Purpose: We aimed to assess the changes in body fat distribution, intraorgan lipid accumulation, and cardiometabolic risk factors after 6 months of gender-affirming hormone therapy (GAHT) in transgender men (TM) and transgender women (TW). Methods: Conducted at the Medical University of Vienna betwe...

Full description

Saved in:
Bibliographic Details
Main Authors: Dorota Sluková, Carola Deischinger, Ivica Just, Ulrike Kaufmann, Siegfried Trattnig, Martin Krššák, Lana Kosi-Trebotic, Juergen Harreiter, Alexandra Kautzky-Willer
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Journal of Clinical & Translational Endocrinology
Subjects:
Gender-affirming hormone therapy
Intraorgan lipid content
Adipose tissue distribution
Glucose homeostasis
Online Access:http://www.sciencedirect.com/science/article/pii/S2214623724000504
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2214623724000504

Similar Items